阿尔凯默斯(ALKS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ALKS 阿尔凯默斯

已收盘 05-01 16:00:00 EDT

30.58

+1.81

+6.29%

盘后30.58

+0.000.00%

18:37 EDT

最高31.32	最低28.54	成交量293.54万
今开28.73	昨收28.77	日振幅9.66%
总市值50.41亿	流通市值49.61亿	总股本1.65亿
成交额8,898万	换手率1.81%	流通股本1.62亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ALKS","market":"US","secType":"STK","nameCN":"阿尔凯默斯","latestPrice":30.58,"timestamp":1746129600000,"preClose":28.77,"halted":0,"volume":2935372,"hourTrading":{"tag":"盘后","latestPrice":30.58,"preClose":30.58,"latestTime":"18:37 EDT","volume":87058,"amount":2662263.45,"timestamp":1746139073377},"delay":0,"floatShares":162215083,"shares":164836227,"eps":2.170046,"marketStatus":"已收盘","change":1.81,"latestTime":"05-01 16:00:00 EDT","open":28.73,"high":31.32,"low":28.54,"amount":88976347.346788,"amplitude":0.096628,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":2.170046,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1746172800000},"marketStatusCode":5,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":28.77,"preHourTrading":{"tag":"盘前","latestPrice":28.8,"preClose":28.77,"latestTime":"08:57 EDT","volume":34,"amount":976.599952,"timestamp":1746104247506},"postHourTrading":{"tag":"盘后","latestPrice":30.58,"preClose":30.58,"latestTime":"18:37 EDT","volume":87058,"amount":2662263.45,"timestamp":1746139073377},"volumeRatio":1.633108,"impliedVol":0.4108,"impliedVolPercentile":0.612},"requestUrl":"/m/hq/s/ALKS/tweets","defaultTab":"tweets","newsList":[{"id":"2532000818","title":"阿尔凯默斯盘中异动 早盘快速上涨5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2532000818","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532000818?lang=zh_cn&edition=full","pubTime":"2025-05-01 21:44","pubTimestamp":1746107047,"startTime":"0","endTime":"0","summary":"北京时间2025年05月01日21时44分，阿尔凯默斯股票出现异动，股价快速上涨5.07%。阿尔凯默斯股票所在的制药行业中，整体跌幅为4.51%。其相关个股中，Talphera, Inc.、阿尔凯默斯、Biofrontera Inc.涨幅较大，Petros Pharmaceuticals, Inc.、大自然药业、Quantum Biopharma Ltd.较为活跃，换手率分别为10.42%、1.52%、1.30%，振幅较大的相关个股有Petros Pharmaceuticals, Inc.、脑再生科技、Talphera, Inc.，振幅分别为32.33%、13.62%、13.45%。阿尔凯默斯从第三方购买活性药物产品或者从其第三方被许可方那里获得活性药物产品，以使用其技术配制产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050121440794e9f80a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050121440794e9f80a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ALKS"],"gpt_icon":0},{"id":"2531670232","title":"瑞银：维持Alkermes评级，由中性调整至中性评级, 目标价由38.00美元调整至33.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2531670232","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531670232?lang=zh_cn&edition=full","pubTime":"2025-04-29 05:45","pubTimestamp":1745876711,"startTime":"0","endTime":"0","summary":"瑞银：维持Alkermes(ALKS.US)评级，由中性调整至中性评级, 目标价由38.00美元调整至33.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042905494597490384&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042905494597490384&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALKS"],"gpt_icon":0},{"id":"2511608563","title":"阿尔凯默斯2024财年实现净利润3.72亿美元，同比减少28.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511608563","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511608563?lang=zh_cn&edition=full","pubTime":"2025-02-16 00:01","pubTimestamp":1739635282,"startTime":"0","endTime":"0","summary":"2月16日，阿尔凯默斯公布财报，公告显示公司2024财年净利润为3.72亿美元，同比减少28.32%；其中营业收入为15.58亿美元，同比减少6.31%，每股基本收益为2.22美元。机构评级：截至2025年2月16日，当前有12家机构对阿尔凯默斯目标价做出预测，其中目标均价为38.58美元，其中最低目标价为30.00美元，最高目标价为46.00美元。阿尔凯默斯从第三方购买活性药物产品，或者从第三方被许可方处获得活性药物产品，利用其技术配制产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250216000145a24729ec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250216000145a24729ec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALKS"],"gpt_icon":0},{"id":"2511520912","title":"阿尔凯默斯盘中异动 临近午盘股价大涨5.02%报35.18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511520912","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511520912?lang=zh_cn&edition=full","pubTime":"2025-02-14 00:44","pubTimestamp":1739465061,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日00时44分，阿尔凯默斯股票出现波动，股价快速拉升5.02%。截至发稿，该股报35.18美元/股，成交量110.005万股，换手率0.68%，振幅6.00%。最近的财报数据显示，该股实现营业收入15.58亿美元，净利润3.72亿美元，每股收益2.22美元，毛利13.11亿美元，市盈率16.19倍。阿尔凯默斯股票所在的制药行业中，整体涨幅为0.72%。阿尔凯默斯从第三方购买活性药物产品，或者从第三方被许可方处获得活性药物产品，利用其技术配制产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021400442298844653&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021400442298844653&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALKS","BK4139"],"gpt_icon":0},{"id":"2511258320","title":"阿尔凯默斯盘中异动 下午盘大幅上涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511258320","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511258320?lang=zh_cn&edition=full","pubTime":"2025-02-13 02:15","pubTimestamp":1739384100,"startTime":"0","endTime":"0","summary":"北京时间2025年02月13日02时15分，阿尔凯默斯股票出现异动，股价大幅上涨5.02%。截至发稿，该股报33.57美元/股，成交量137.54万股，换手率0.85%，振幅6.48%。机构评级方面，在所有9家参与评级的机构中，78%的券商给予买入建议，22%的券商给予持有建议，无券商给予卖出建议。阿尔凯默斯股票所在的制药行业中，整体涨幅为0.52%。阿尔凯默斯从第三方购买活性药物产品，或者从第三方被许可方处获得活性药物产品，利用其技术配制产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213021501abcc8e02&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213021501abcc8e02&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALKS","BK4139"],"gpt_icon":0},{"id":"1107457445","title":"异动解读 | 阿尔凯默斯2024财年业绩超预期,促公司盘前大涨11.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=1107457445","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1107457445?lang=zh_cn&edition=full","pubTime":"2025-02-12 21:44","pubTimestamp":1739367870,"startTime":"0","endTime":"0","summary":"生物制药公司阿尔凯默斯今日盘前大涨11.61%,引发市场关注。从公司最新财报来看,其业绩表现优异或是股价上涨的主因。阿尔凯默斯2024财年调整后每股收益达2.92美元,超出分析师预期的2.66美元,同比增长24.79%;全年销售额15.6亿美元,亦超出预期15.1亿美元,同比大增93.66%。展望2025年,阿尔凯默斯预计总收入将介于13.4亿至14.3亿美元,主力产品VIVITROL、ARISTADAi和LYBALVI净销售额合计达到8.15亿至8.35亿美元。可喜的财务表现和前景预期,支撑了阿尔凯默斯股价今日走高。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ALKS"],"gpt_icon":0},{"id":"1151120116","title":"Alkermes 预测 2025 年销售额为 13.4 亿美元至 14.3 亿美元，市场预期为 14 亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1151120116","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1151120116?lang=zh_cn&edition=full","pubTime":"2025-02-12 20:07","pubTimestamp":1739362046,"startTime":"0","endTime":"0","summary":"根据 GAAP，除特别说明外，所有数字均按照此标准计算。- 实际税率：约 17%以上内容来自Benzinga Earnings专栏，原文如下：Financial Expectations for 2025All line items are according to GAAP, except as otherwise noted.In millions2025 ExpectationsTotal Revenues$1,340 – $1,430VIVITROL Net Sales$440 – $460ARISTADAi Net Sales$335 – $355LYBALVI Net Sales$320 – $340Cost of Goods Sold$185 – $205R&D Expenses$305 – $335SG&A Expenses$655 – $685GAAP Net Income a$175 – $205EBITDA$215 – $245Adjusted EBITDA$310 – $340Effective Tax Rate~17%","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALKS"],"gpt_icon":0},{"id":"1107280981","title":"Alkermes 2024年第四季度调整后每股收益1.04美元，超出预期的0.79美元，销售额为4.2999亿美元，超过预期的3.7974亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1107280981","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1107280981?lang=zh_cn&edition=full","pubTime":"2025-02-12 20:06","pubTimestamp":1739362010,"startTime":"0","endTime":"0","summary":"Alkermes公布季度每股收益1.04美元，超出分析师一致预期的0.79美元，超出幅度为31.65%。这比去年同期的销售额3.7748亿美元增长了13.91%。以上内容来自Benzinga Earnings专栏，原文如下：Alkermes  reported quarterly earnings of $1.04 per share which beat the analyst consensus estimate of $0.79 by 31.65 percent. This is a 116.67 percent increase over earnings of $0.48 per share from the same period last year.  The company reported quarterly sales of $429.99 million which beat the analyst consensus estimate of $379.74 million by 13.23 percent.  This is a 13.91 percent in","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALKS"],"gpt_icon":0},{"id":"1139182578","title":"Alkermes公司2024财年调整后每股收益为$2.92，超出预期$2.66；销售额为$15.6亿美元，超出预期$15.1亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1139182578","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1139182578?lang=zh_cn&edition=full","pubTime":"2025-02-12 20:06","pubTimestamp":1739361987,"startTime":"0","endTime":"0","summary":"Alkermes报告季度每股收益$2.92，超出分析师共识预期$2.66，增长了 9.77%。相比去年同期的每股收益$2.34，本次业绩增加了24.79%。以上内容来自Benzinga Earnings专栏，原文如下：Alkermes  reported quarterly earnings of $2.92 per share which beat the analyst consensus estimate of $2.66 by 9.77 percent. This is a 24.79 percent increase over earnings of $2.34 per share from the same period last year.  The company reported quarterly sales of $1.56 billion which beat the analyst consensus estimate of $1.51 billion by 3.32 percent.  This is a 93.66B percent increase ov","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Alkermes公司2024财年调整后每股收益为$2.92，超出预期$2.66；销售额为$15.6亿美元，超出预期$15.1亿美元","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALKS"],"gpt_icon":0},{"id":"2510358174","title":"Alkermes(ALKS.US)获德银首次覆盖，给予买入评级, 目标价40.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2510358174","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510358174?lang=zh_cn&edition=full","pubTime":"2025-02-12 02:02","pubTimestamp":1739296955,"startTime":"0","endTime":"0","summary":"Alkermes(ALKS.US)获德银首次覆盖，给予买入评级, 目标价40.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/12020248092619.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ALKS"],"gpt_icon":0},{"id":"2505204107","title":"阿尔凯默斯盘中异动 股价大涨5.00%报31.72美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505204107","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505204107?lang=zh_cn&edition=full","pubTime":"2025-01-24 01:49","pubTimestamp":1737654590,"startTime":"0","endTime":"0","summary":"北京时间2025年01月24日01时49分，阿尔凯默斯股票出现波动，股价急速上涨5.00%。截至发稿，该股报31.72美元/股，成交量92.8667万股，换手率0.57%，振幅6.54%。机构评级方面，在所有13家参与评级的机构中，62%的券商给予买入建议，31%的券商给予持有建议，7%的券商给予卖出建议。阿尔凯默斯股票所在的制药行业中，整体涨幅为0.72%。阿尔凯默斯从第三方购买活性药物产品，或者从第三方被许可方处获得活性药物产品，利用其技术配制产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124014950960e6991&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124014950960e6991&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALKS","BK4139"],"gpt_icon":0},{"id":"2489411547","title":"阿尔凯默斯盘中异动 大幅上涨5.27%报31.04美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2489411547","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489411547?lang=zh_cn&edition=full","pubTime":"2024-12-04 23:57","pubTimestamp":1733327832,"startTime":"0","endTime":"0","summary":"北京时间2024年12月04日23时57分，阿尔凯默斯股票出现波动，股价急速拉升5.27%。截至发稿，该股报31.04美元/股，成交量27.4762万股，换手率0.17%，振幅5.26%。机构评级方面，在所有13家参与评级的机构中，62%的券商给予买入建议，31%的券商给予持有建议，7%的券商给予卖出建议。阿尔凯默斯股票所在的制药行业中，整体涨幅为0.89%。阿尔凯默斯从第三方购买活性药物产品，或者从第三方被许可方处获得活性药物产品，利用其技术配制产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204235712abf5f20b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204235712abf5f20b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ALKS"],"gpt_icon":0},{"id":"2485973912","title":"阿尔凯默斯盘中异动 下午盘大幅上涨5.02%报29.09美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485973912","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485973912?lang=zh_cn&edition=full","pubTime":"2024-11-23 02:10","pubTimestamp":1732299037,"startTime":"0","endTime":"0","summary":"北京时间2024年11月23日02时10分，阿尔凯默斯股票出现异动，股价急速上涨5.02%。截至发稿，该股报29.09美元/股，成交量83.6742万股，换手率0.52%，振幅5.42%。机构评级方面，在所有13家参与评级的机构中，62%的券商给予买入建议，31%的券商给予持有建议，7%的券商给予卖出建议。阿尔凯默斯股票所在的制药行业中，整体涨幅为0.85%。阿尔凯默斯从第三方购买活性药物产品，或者从第三方被许可方处获得活性药物产品，利用其技术配制产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123021037abd7ea1f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123021037abd7ea1f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALKS","BK4139"],"gpt_icon":0},{"id":"2481688575","title":"阿尔凯默斯盘中异动 早盘快速拉升5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481688575","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481688575?lang=zh_cn&edition=full","pubTime":"2024-11-05 22:36","pubTimestamp":1730817404,"startTime":"0","endTime":"0","summary":"北京时间2024年11月05日22时36分，阿尔凯默斯股票出现异动，股价急速拉升5.04%。截至发稿，该股报27.93美元/股，成交量27.9343万股，换手率0.17%，振幅2.37%。阿尔凯默斯股票所在的制药行业中，整体跌幅为0.50%。阿尔凯默斯从第三方购买活性药物产品，或者从第三方被许可方处获得活性药物产品，利用其技术配制产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105223644aba23dfa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105223644aba23dfa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ALKS"],"gpt_icon":0},{"id":"2478645831","title":"阿尔凯默斯2024财年第三财季实现净利润92.80百万美元，同比增加94.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478645831","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478645831?lang=zh_cn&edition=full","pubTime":"2024-10-28 00:00","pubTimestamp":1730044840,"startTime":"0","endTime":"0","summary":"10月28日，阿尔凯默斯公布财报，公告显示公司2024财年第三财季净利润为92.80百万美元，同比增加94.30%；其中营业收入为3.78亿美元，同比减少0.79%，每股基本收益为0.57美元。机构评级：截至2024年10月28日，当前有12家机构对阿尔凯默斯目标价做出预测，其中目标均价为32.25美元，其中最低目标价为21.00美元，最高目标价为43.00美元。阿尔凯默斯从第三方购买活性药物产品，或者从第三方被许可方处获得活性药物产品，利用其技术配制产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028000055ab78d232&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028000055ab78d232&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALKS"],"gpt_icon":0},{"id":"2477023639","title":"阿尔凯默斯盘中异动 早盘大幅下跌6.43%报26.06美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477023639","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477023639?lang=zh_cn&edition=full","pubTime":"2024-10-24 21:30","pubTimestamp":1729776650,"startTime":"0","endTime":"0","summary":"北京时间2024年10月24日21时30分，阿尔凯默斯股票出现波动，股价大幅下挫6.43%。截至发稿，该股报26.06美元/股，成交量27.902万股，换手率0.17%，振幅1.58%。阿尔凯默斯股票所在的制药行业中，整体涨幅为0.00%。阿尔凯默斯从第三方购买活性药物产品，或者从第三方被许可方处获得活性药物产品，利用其技术配制产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102421305098e3e3ad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102421305098e3e3ad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ALKS"],"gpt_icon":0},{"id":"2474046585","title":"阿尔凯默斯盘中异动 股价大涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474046585","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474046585?lang=zh_cn&edition=full","pubTime":"2024-10-12 02:35","pubTimestamp":1728671705,"startTime":"0","endTime":"0","summary":"北京时间2024年10月12日02时35分，阿尔凯默斯股票出现波动，股价急速拉升5.01%。截至发稿，该股报28.74美元/股，成交量79.2642万股，换手率0.48%，振幅5.26%。阿尔凯默斯股票所在的制药行业中，整体涨幅为1.30%。阿尔凯默斯从第三方购买活性药物产品，或者从第三方被许可方处获得活性药物产品，利用其技术配制产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101202350598e3bf11&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101202350598e3bf11&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALKS","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.alkermes.com","stockEarnings":[{"period":"1week","weight":0.0597},{"period":"1month","weight":-0.1287},{"period":"3month","weight":-0.0984},{"period":"6month","weight":0.0869},{"period":"1year","weight":0.1724},{"period":"ytd","weight":0.0003}],"compareEarnings":[{"period":"1week","weight":0.0357},{"period":"1month","weight":-0.0087},{"period":"3month","weight":-0.0835},{"period":"6month","weight":-0.0289},{"period":"1year","weight":0.1047},{"period":"ytd","weight":-0.0538}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Alkermes Public Limited Company于2011年5月4日在爱尔兰成立为一家私人有限公司，名称为Antler Science Two Limited（注册号498284）。该公司是一家完全整合的全球性生物制药公司，利用其科学专长和专有技术开发创新药物，改善患者的治疗效果。公司拥有多元化的产品组合，包括20多种商业药物产品和大量临床候选产品，用于治疗中枢神经系统疾病，如成瘾、精神分裂症和抑郁症。","yearOnYearQuotes":[{"month":1,"riseRate":0.764706,"avgChangeRate":0.087386},{"month":2,"riseRate":0.441176,"avgChangeRate":0.05532},{"month":3,"riseRate":0.411765,"avgChangeRate":-0.046005},{"month":4,"riseRate":0.441176,"avgChangeRate":-0.028743},{"month":5,"riseRate":0.545455,"avgChangeRate":0.051471},{"month":6,"riseRate":0.484848,"avgChangeRate":0.005494},{"month":7,"riseRate":0.545455,"avgChangeRate":0.025996},{"month":8,"riseRate":0.470588,"avgChangeRate":0.042399},{"month":9,"riseRate":0.411765,"avgChangeRate":0.000967},{"month":10,"riseRate":0.5,"avgChangeRate":0.03313},{"month":11,"riseRate":0.5,"avgChangeRate":-0.011149},{"month":12,"riseRate":0.705882,"avgChangeRate":0.057642}],"exchange":"NASDAQ","name":"阿尔凯默斯","nameEN":"Alkermes PLC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"阿尔凯默斯(ALKS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供阿尔凯默斯(ALKS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"阿尔凯默斯,ALKS,阿尔凯默斯股票,阿尔凯默斯股票老虎,阿尔凯默斯股票老虎国际,阿尔凯默斯行情,阿尔凯默斯股票行情,阿尔凯默斯股价,阿尔凯默斯股市,阿尔凯默斯股票价格,阿尔凯默斯股票交易,阿尔凯默斯股票购买,阿尔凯默斯股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"阿尔凯默斯(ALKS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供阿尔凯默斯(ALKS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}